CAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research Collaboration
Shinshu University Hospital's expertise in CAR T-cell therapy R&D and clinical application will be combined with Teijin Regenet's manufacturing and quality-management expertise cultivated through its CDMO business for regenerative medicine products. The post CAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research Collaboration appeared first on GEN - Genetic Engineering…
Teijin, Teijin Regenet, and Shinshu University Hospital, all Japanese entities, have formed a collaborative research agreement focused on manufacturing technologies for cell and gene therapy products. This partnership aims to enhance manufacturing methods and bolster Japan's infrastructure for cell and gene therapies, ultimately contributing to the wider accessibility of these innovative treatments.
Cell and gene therapies, including CAR T-cell therapies, are anticipated to become crucial treatment options for cancer and other challenging diseases. However, in Japan, the expansion of specialized manufacturing personnel and facilities poses substantial challenges, highlighting the necessity for a more resilient and sustainable supply framework.
The joint research agreement unites Shinshu University Hospital's expertise in CAR T-cell therapy research and clinical application with Teijin Regenet's manufacturing and quality-management skills, honed through its contract manufacturing organization (CMO) for regenerative medicine products. Together, the partners intend to improve manufacturing technologies and fortify the manufacturing base for cell and gene therapies.
The collaboration will also leverage the Cell Processing Center (CPC) at Shinshu University Hospital to investigate potential manufacturing automation and efficiency improvements. Furthermore, the partners will gather practical knowledge on quality testing technologies and quality-control methodologies.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
